Cargando…
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary
AIM: The objective of this article is to evaluate the relationship between the changes in prescriptions of antiosteoporotic drugs (mainly the rapid fall in the use of bisphosphonates [BPs]) and standardized hip fracture (HF) rates over the period 2005–2008 in the Australian Capital Territory (ACT)....
Autores principales: | Fisher, Alex, Martin, Jodie, Srikusalanukul, Wichat, Davis, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010171/ https://www.ncbi.nlm.nih.gov/pubmed/21228901 http://dx.doi.org/10.2147/CIA.S13909 |
Ejemplares similares
-
Interactions between Serum Adipokines and Osteocalcin in Older Patients with Hip Fracture
por: Fisher, Alexander, et al.
Publicado: (2012) -
Poststroke Hip Fracture: Prevalence, Clinical Characteristics, Mineral-Bone Metabolism, Outcomes, and Gaps in Prevention
por: Fisher, Alexander, et al.
Publicado: (2013) -
Six-fold increased risk of hip fracture in older Australians (≥60 years) with dementia
por: Fisher, Alexander A., et al.
Publicado: (2006) -
Liver Function Parameters in Hip Fracture Patients: Relations to Age, Adipokines, Comorbidities and Outcomes
por: Fisher, Leon, et al.
Publicado: (2015) -
Clinical profiles and risk factors for outcomes in older patients with cervical and trochanteric hip fracture: similarities and differences
por: Fisher, Alexander A, et al.
Publicado: (2012)